Sns Financial Group, LLC Bristol Myers Squibb CO Transaction History

Sns Financial Group, LLC

$994 Million
Q3 2024

A detailed history of Sns Financial Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sns Financial Group, LLC holds 4,077 shares of BMY stock, worth $235,161. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,077

Holding current value

$235,161

% of portfolio

0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$39.66 - $51.75 $161,693 - $210,984	4,077 New	4,077 $210,000
Q1 2024 Apr 24, 2024	BUY	$47.98 - $54.4 $1,919 - $2,176	40 Added 0.71%	5,658 $306,000
Q4 2023 Jan 22, 2024	BUY	$48.48 - $57.85 $9,065 - $10,817	187 Added 3.44%	5,618 $288,000
Q3 2023 Oct 19, 2023	SELL	$57.89 - $64.73 $6,715 - $7,508	-116 Reduced 2.09%	5,431 $315,000
Q2 2023 Jul 17, 2023	SELL	$63.71 - $70.74 $17,711 - $19,665	-278 Reduced 4.77%	5,547 $354,000
Q1 2023 Apr 28, 2023	SELL	$65.71 - $74.53 $9,593 - $10,881	-146 Reduced 2.45%	5,825 $403,000
Q4 2022 Jan 25, 2023	BUY	$68.48 - $81.09 $18,078 - $21,407	264 Added 4.63%	5,971 $0
Q3 2022 Oct 12, 2022	SELL	$0.13 - $76.84 $1 - $845	-11 Reduced 0.19%	5,707 $406,000
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $23,891 - $26,313	-329 Reduced 5.44%	5,718 $444,000
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $20,226 - $24,253	-329 Reduced 5.16%	6,047 $441,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $10,457 - $12,191	-195 Reduced 2.97%	6,376 $397,000
Q2 2021 Aug 02, 2021	SELL	$61.91 - $67.42 $15,725 - $17,124	-254 Reduced 3.72%	6,571 $439,000
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $87,071 - $98,668	1,508 Added 28.36%	6,825 $423,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $29,978 - $33,220	522 Added 10.89%	5,317 $321,000
Q2 2020 Aug 06, 2020	SELL	$54.82 - $64.09 $8,387 - $9,805	-153 Reduced 3.09%	4,795 $282,000
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $11,136 - $16,183	240 Added 5.1%	4,948 $276,000
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $231,680 - $302,206	4,708 New	4,708 $302,000
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $197,535 - $235,536	-4,378 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$55.19 - $62.25 $3,476 - $3,921	-63 Reduced 1.42%	4,378 $272,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $2,526 - $3,149	-50 Reduced 1.11%	4,441 $246,000
Q1 2018 May 02, 2018	SELL	$59.92 - $68.98 $54,647 - $62,909	-912 Reduced 16.88%	4,491 $284,000
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $17,442 - $19,016	291 Added 5.69%	5,403 $331,000
Q3 2017 Nov 07, 2017	SELL	$55.23 - $63.74 $8,671 - $10,007	-157 Reduced 2.98%	5,112 $326,000
Q2 2017 Aug 09, 2017	BUY	N/A	5,269	5,269 $293,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sns Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sns Financial Group, LLC with notifications on news.

Account

Sns Financial Group, LLC Bristol Myers Squibb CO Transaction History